Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB1 | P05556 | 11/20 | 0.45 |
| ▸ | ITGA4 | P13612 | 11/20 | 0.45 |
| ▸ | ITGB7 | P26010 | 1/20 | 0.43 |
| ▸ | CAPN1 | P07384 | 4/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5163629 | 0.82 | ITGB1 (0.63) | ITGB1ITGA4ITGB7CAPN1 | |
| SCHEMBL5679526 | 0.81 | ITGB1 (0.61) | ITGB1ITGA4CAPN1 | |
| SCHEMBL5164693 | 0.76 | ITGB1 (0.53) | ITGB1ITGA4ITGB7CAPN1 | |
| SCHEMBL5679375 | 0.75 | CACNA1B (0.55) | ITGB1ITGA4ITGB7CAPN1 | |
| Lithium Ion SCHEMBL5200346 | 0.75 | CAPN1 (0.53) | ITGB1ITGA4CAPN1ALDH1A1CYP2D6 | |
| SCHEMBL5679790 | 0.74 | CAPN1 (0.54) | ITGB1ITGA4CAPN1 | |
| SCHEMBL5679669 | 0.71 | ITGB1 (0.63) | ITGB1ITGA4CAPN1ALDH1A1CYP2D6 | |
| SCHEMBL5163953 | 0.70 | ITGB1 (0.50) | ITGB1ITGA4CAPN1ALDH1A1CYP2D6 | |
| SCHEMBL5164182 | 0.69 | ITGB1 (0.74) | ITGB1ITGA4CAPN1 | |
| SCHEMBL5165158 | 0.69 | ITGB1 (0.74) | ITGB1ITGA4CAPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6407066-B1 | Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4 | ELAN PHARMACEUTICALS, INC. | 2002-06-18 | — | — | US | claimed |